Steve Pakola, Chief Medical Officer: Regenxbio RGNX Sell · Filed 05/13

Trade details

Type: Insider sale
Amount: $168,705.18
Shares · price: 15,309 sh · $11.02 a share
Held after: 232,617 sh
Stock: Regenxbio RGNX
Person: Steve PakolaChief Medical Officer
Trade date: 26/05/11
Filed: 26/05/13
Days to filing: 2 days

Sold 6.2% of holdings

Share of holding sold: 6.2%

Regenxbio trades, last 26 weeks

What else happened in Regenxbio around then

Filed or reported within 30 days of the trade day · 04/11~06/10

Steve Pakola's recent trades

Steve PakolaChief Medical Officer
Planned sale10b5-1 planRegenxbio
Planned sale10b5-1 plan
Regenxbio
RGNX
$517.6K
43,206 sh
$517.6K
Filed 07/01
Traded 07/01
Steve PakolaChief Medical Officer
Planned sale10b5-1 planRegenxbio
Planned sale10b5-1 plan
Regenxbio
RGNX
$368.4K
34,917 sh
$368.4K
Filed 05/11
Traded 05/11
Steve PakolaChief Medical Officer
Sell10b5-1 planRegenxbio
Sell10b5-1 plan
Regenxbio
RGNX
$53K
5,124 sh
$53K
Filed 03/12
Traded 03/10
Steve PakolaChief Medical Officer
Planned sale10b5-1 planRegenxbio
Planned sale10b5-1 plan
Regenxbio
RGNX
$53.2K
5,124 sh
$53.2K
Filed 03/10
Traded 03/10
Steve PakolaChief Medical Officer
Sell10b5-1 planRegenxbio
Sell10b5-1 plan
Regenxbio
RGNX
$365.2K
12,878 sh
$365.2K
Filed 24/03/07
Traded 24/03/05

Steve Pakola, Chief Officer — sold $168.7K of Regenxbio RGNX · 6.2% of holdings · 10b5-1 plan | Whalegun